Jornal Vascular Brasileiro
https://jvascbras.org/article/doi/10.1590/1677-5449.210021
Jornal Vascular Brasileiro
Original Article

Impacto da pandemia da COVID-19 sobre o tratamento medicamentoso dos pacientes com doença arterial periférica: um estudo observacional transversal

Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study

Heloisa Amaral Braghieri; Marília de Almeida Correia; Juliana Ferreira de Carvalho; Paulo Longano; Nelson Wolosker; Gabriel Grizzo Cucato; Raphael Mendes Ritti-Dias; Hélcio Kanegusuku

Downloads: 0
Views: 148

Resumo

Resumo: Contexto: A pandemia do Coronavírus 2019 (COVID-19) tem afetado negativamente o comportamento da população. Nesse contexto, o impacto da pandemia da COVID-19 no tratamento medicamentoso dos pacientes com doença arterial periférica (DAP) e claudicação intermitente (CI) permanece obscuro.

Objetivos: Analisar o impacto da pandemia da COVID-19 no tratamento medicamentoso dos pacientes com DAP e CI.

Métodos: Neste estudo observacional transversal, 136 pacientes com DAP e CI, recrutados do nosso banco de dados, responderam por telefone um questionário envolvendo as seguintes questões: a) cuidados com a COVID-19; b) saúde global; c) tratamento das doenças. Posteriormente, os pacientes foram divididos em dois grupos, de acordo com a dificuldade para a aquisição dos medicamentos (DAM: dificuldade e SDAM: sem dificuldade), para a comparação da saúde global entre os dois grupos.

Resultados: Dezessete porcento dos pacientes reportaram dificuldades para a aquisição dos medicamentos durante a pandemia. Uma maior prevalência desses pacientes reportou estar mais triste (56,5% versus 24,8%, p < 0,01) e com mais dificuldades para dormir (56,5% versus 24,8%, p < 0,01) em relação aos pacientes do grupo SDAM. Os grupos não apresentaram diferenças para o declínio na capacidade de caminhada, ansiedade, estresse e depressão (p > 0,05).

Conclusões: Uma maior prevalência de pacientes do grupo DAM reportou estar mais triste e com mais dificuldade para dormir em comparação ao grupo SDAM durante a pandemia da COVID-19.

Palavras-chave

COVID-19, isolamento social, claudicação intermitente, tratamento medicamentoso, saúde, SARS-CoV-2

Abstract

Background: The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population’s behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. Objectives: To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. Methods: In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnaire by telephone involving the following questions: a) precautions related to COVID-19; b) general health status; and c) treatment of diseases. Subsequently, patients were divided into two groups according to difficulty in obtaining their drugs (DOD: difficulty obtaining drugs, or NDOD: no difficulty obtaining drugs) and overall health was compared between groups. Results: Seventeen percent of patients reported difficulties with obtaining drugs during the pandemic. A higher proportion of these patients reported being sadder (56.5% vs. 24.8%, P < 0.01) and having more difficulty sleeping (56.5% vs. 24.8%, P < 0.01) than of the patients in the NDOD group (P 0.05). Conclusions: A higher proportion of patients in the DOD group reported being sadder and having greater difficulty sleeping compared to the NDOD group during the COVID-19 pandemic.

Keywords

COVID-19; social isolation; intermittent claudication; drug treatment; health; SARS-CoV-2.

References

1 Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998;18(2):185-92. http://dx.doi.org/10.1161/01.ATV.18.2.185. PMid:9484982.

2 Muir RL. Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention. J Vasc Nurs. 2009;27(2):26-30. http://dx.doi.org/10.1016/j.jvn.2009.03.001. PMid:19486852.

3 Wolosker N, Rosoky RA, Nakano L, Basyches M, Puech-Leão P. Predictive value of the ankle-brachial index in the evaluation of intermittent claudication. Rev Hosp Clin Fac Med Sao Paulo. 2000;55(2):61-4. http://dx.doi.org/10.1590/S0041-87812000000200005. PMid:10959125.

4 Farah BQ, Souza Barbosa JP, Cucato GG, et al. Predictors of walking capacity in peripheral arterial disease patients. Clinics. 2013;68(4):537-41. http://dx.doi.org/10.6061/clinics/2013(04)16. PMid:23778336.

5 Brevetti G, Oliva G, Di Giacomo S, Bucur R, Annecchini R, Di Iorio A. Intermittent claudication in older patients: risk factors, cardiovascular comorbidity, and severity of peripheral arterial disease. J Am Geriatr Soc. 2001;49(9):1261-2. http://dx.doi.org/10.1046/j.1532-5415.2001.49248.x. PMid:11559394.

6 Spronk S, White JV, Bosch JL, Hunink MG. Impact of claudication and its treatment on quality of life. Semin Vasc Surg. 2007;20(1):3-9. http://dx.doi.org/10.1053/j.semvascsurg.2007.02.003. PMid:17386358.

7 Wolrd Health Organization [site na Internet]. Coronavirus disease (COVID-19) pandemic. 2021 [citado 26 jan 2021]. https://www.who.int/emergencies/ diseases /novel-coronavirus-2019

8 Peçanha T, Goessler KF, Roschel H, Gualano B. Social isolation during the COVID-19 pandemic can increase physical inactivity and the global burden of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2020;318(6):H1441-6. http://dx.doi.org/10.1152/ajpheart.00268.2020. PMid:32412779.

9 Lofrano-Prado MC, Prado WL, Botero JP, et al. The same storm but not same the boat: Effects of COVID-19 stay-at-home order on mental health in individuals with overweight. Clin Obes. 2021;11(1):e12425. http://dx.doi.org/10.1111/cob.12425. PMid:33217224.

10 Diniz TA, Christofaro DGD, Tebar WR, et al. Reduction of physical activity levels during the COVID-19 pandemic might negatively disturb sleep patern. Front Psychol. 2020;11:586157. http://dx.doi.org/10.3389/fpsyg.2020.586157. PMid:33424702.

11 Coronado PJ, Fasero M, Otero B, et al. Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement. Maturitas. 2021;144:4-10. http://dx.doi.org/10.1016/j.maturitas.2020.09.004. PMid:33358207.

12 Dopheide JF, Veit J, Ramadani H, et al. Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease. Eur Heart J Cardiovasc Pharmacother. 2019. No prelo. http://dx.doi.org/10.1093/ehjcvp/pvz081. PMid:31886861.

13 Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-909. http://dx.doi.org/10.1161/CIR.0b013e318276fbcb. PMid:23159553.

14 Khan A, Althunayyan S, Alsofayan Y, et al. Risk factors associated with worse outcomes in COVID-19: a retrospective study in Saudi Arabia. East Mediterr Health J. 2020;26(11):1371-80. http://dx.doi.org/10.26719/emhj.20.130. PMid:33226105.

15 Rezende LFM, Thome B, Schveitzer MC, Souza-Júnior PRB, Szwarcwald CL. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil. Rev Saude Publica. 2020;54:50. http://dx.doi.org/10.11606/s1518-8787.2020054002596. PMid:32491091.

16 Casares M, Khan H. The timing and intensity of social distancing to flatten the COVID-19 Curve: the case of Spain. Int J Environ Res Public Health. 2020;17(19):7283. http://dx.doi.org/10.3390/ijerph17197283. PMid:33036132.

17 Hsiang S, Allen D, Annan-Phan S, et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature. 2020;584(7820):262-7. http://dx.doi.org/10.1038/s41586-020-2404-8. PMid:32512578.

18 Coulthard H, Sharps M, Cunliffe L, van den Tol A. Eating in the lockdown the Covid 19 pandemic; self-reported changes in eating behaviour, and associations with BMI, eating style, coping and health anxiety. Appetite. 2021;161:105082. http://dx.doi.org/10.1016/j.appet.2020.105082. PMid:33476651.

19 Wang Q, Luo Y, Lv C, et al. Nonadherence to treatment and patient-reported outcomes of psoriasis during the COVID-19 epidemic: a web-based survey. Patient Prefer Adherence. 2020;14:1403-9. http://dx.doi.org/10.2147/PPA.S263843. PMid:32884243.

20 Almeida Correia M, Andrade-Lima A, Mesquita de Oliveira PL, et al. Translation and Validation of the Brazilian-Portuguese Short Version of Vascular Quality of Life Questionnaire in Peripheral Artery Disease Patients with Intermittent Claudication Symptoms. Ann Vasc Surg. 2018;51:48-54.e1. http://dx.doi.org/10.1016/j.avsg.2018.02.026. PMid:29772330.

21 Maksimovic M, Vlajinac H, Marinkovic J, Kocev N, Voskresenski T, Radak D. Health-related quality of life among patients with peripheral arterial disease. Angiology. 2014;65(6):501-6. http://dx.doi.org/10.1177/0003319713488640. PMid:23657177.

22 Rich K. The connection between obstructive sleep apnea and peripheral artery disease. J Vasc Nurs. 2020;38(4):195-7. http://dx.doi.org/10.1016/j.jvn.2020.10.002. PMid:33279111.

23 Farah BQ, Ritti-Dias RM, Cucato GG, Montgomery PS, Gardner AW. Factors associated with sedentary behavior in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2016;52(6):809-14. http://dx.doi.org/10.1016/j.ejvs.2016.07.082. PMid:27769867.

24 Li W, Chen X, Feng H. Impact of COVID-19 on peripheral arterial disease treatment. Ann Vasc Surg. 2020;67:6-7. http://dx.doi.org/10.1016/j.avsg.2020.05.045. PMid:32502682.
 


Submitted date:
01/29/2021

Accepted date:
04/22/2021

60d4c758a953957b3e5c6263 jvb Articles

J Vasc Bras

Share this page
Page Sections